Another Covid-19 breakthrough as researchers find inhaled multiple sclerosis drug proven to work

Just 13 per cent of Covid-19 hospital patients given SNG001 fell ill enough to need intensive care, compared to 22 per cent of those on a placebo, the Southampton University study found.